DRAGANFLY INC (DPRO)

CA26142Q2053 - Common Stock

3.55  +0.26 (+7.9%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to DPRO. DPRO was compared to 65 industry peers in the Aerospace & Defense industry. DPRO may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, DPRO is valued expensive at the moment.



0

1. Profitability

1.1 Basic Checks

DPRO had negative earnings in the past year.
In the past year DPRO has reported a negative cash flow from operations.
In the past 5 years DPRO always reported negative net income.
DPRO had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

DPRO has a worse Return On Assets (-156.46%) than 95.31% of its industry peers.
DPRO has a Return On Equity of -305.99%. This is amonst the worse of the industry: DPRO underperforms 84.38% of its industry peers.
Industry RankSector Rank
ROA -156.46%
ROE -305.99%
ROIC N/A
ROA(3y)-170.28%
ROA(5y)-193.62%
ROE(3y)-2029.35%
ROE(5y)-1360.53%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

DPRO has a Gross Margin (24.58%) which is in line with its industry peers.
In the last couple of years the Gross Margin of DPRO has declined.
The Profit Margin and Operating Margin are not available for DPRO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.91%
GM growth 5Y-14.11%

3

2. Health

2.1 Basic Checks

DPRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DPRO has more shares outstanding
The number of shares outstanding for DPRO has been reduced compared to 5 years ago.
Compared to 1 year ago, DPRO has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -18.08, we must say that DPRO is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -18.08, DPRO is not doing good in the industry: 95.31% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.07 indicates that DPRO is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.07, DPRO belongs to the top of the industry, outperforming 84.38% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z -18.08
ROIC/WACCN/A
WACC8.46%

2.3 Liquidity

A Current Ratio of 1.94 indicates that DPRO should not have too much problems paying its short term obligations.
DPRO's Current ratio of 1.94 is in line compared to the rest of the industry. DPRO outperforms 46.88% of its industry peers.
A Quick Ratio of 1.54 indicates that DPRO should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.54, DPRO is doing good in the industry, outperforming 65.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.94
Quick Ratio 1.54

5

3. Growth

3.1 Past

DPRO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -247.96%.
The Revenue for DPRO has decreased by -15.66% in the past year. This is quite bad
DPRO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.43% yearly.
EPS 1Y (TTM)-247.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.85%
Revenue 1Y (TTM)-15.66%
Revenue growth 3Y14.53%
Revenue growth 5Y36.43%
Sales Q2Q%-11.82%

3.2 Future

DPRO is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -38.90% yearly.
DPRO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 45.62% yearly.
EPS Next Y-832.69%
EPS Next 2Y-67.09%
EPS Next 3Y-38.9%
EPS Next 5YN/A
Revenue Next Year-4.5%
Revenue Next 2Y42.42%
Revenue Next 3Y45.62%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DPRO. In the last year negative earnings were reported.
Also next year DPRO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

DPRO's earnings are expected to decrease with -38.90% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-67.09%
EPS Next 3Y-38.9%

0

5. Dividend

5.1 Amount

No dividends for DPRO!.
Industry RankSector Rank
Dividend Yield N/A

DRAGANFLY INC

NASDAQ:DPRO (1/10/2025, 10:43:46 AM)

3.55

+0.26 (+7.9%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)N/A N/A
Inst Owners7.91%
Inst Owner Change0%
Ins Owners1.28%
Ins Owner ChangeN/A
Market Cap15.02M
Analysts82.5
Price Target4.37 (23.1%)
Short Float %3.86%
Short Ratio0.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)27.44%
Min EPS beat(2)-40.06%
Max EPS beat(2)94.93%
EPS beat(4)3
Avg EPS beat(4)35.67%
Min EPS beat(4)-40.06%
Max EPS beat(4)94.93%
EPS beat(8)4
Avg EPS beat(8)-14.1%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-29.03%
Min Revenue beat(2)-40.03%
Max Revenue beat(2)-18.03%
Revenue beat(4)0
Avg Revenue beat(4)-38.76%
Min Revenue beat(4)-71.67%
Max Revenue beat(4)-18.03%
Revenue beat(8)0
Avg Revenue beat(8)-32.02%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-17.41%
PT rev (3m)-19.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2162.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-2245.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-13.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.84%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.69
P/FCF N/A
P/OCF N/A
P/B 4.96
P/tB 5.01
EV/EBITDA N/A
EPS(TTM)-2.37
EYN/A
EPS(NY)-1.14
Fwd EYN/A
FCF(TTM)-2.16
FCFYN/A
OCF(TTM)-2.13
OCFYN/A
SpS0.96
BVpS0.72
TBVpS0.71
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -156.46%
ROE -305.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.58%
FCFM N/A
ROA(3y)-170.28%
ROA(5y)-193.62%
ROE(3y)-2029.35%
ROE(5y)-1360.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.91%
GM growth 5Y-14.11%
F-Score5
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 25.94%
Cap/Sales 2.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.94
Quick Ratio 1.54
Altman-Z -18.08
F-Score5
WACC8.46%
ROIC/WACCN/A
Cap/Depr(3y)56.32%
Cap/Depr(5y)72.3%
Cap/Sales(3y)3.87%
Cap/Sales(5y)3.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-247.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.85%
EPS Next Y-832.69%
EPS Next 2Y-67.09%
EPS Next 3Y-38.9%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.66%
Revenue growth 3Y14.53%
Revenue growth 5Y36.43%
Sales Q2Q%-11.82%
Revenue Next Year-4.5%
Revenue Next 2Y42.42%
Revenue Next 3Y45.62%
Revenue Next 5YN/A
EBIT growth 1Y50.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year50.96%
EBIT Next 3Y21.54%
EBIT Next 5YN/A
FCF growth 1Y23.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.13%
OCF growth 3YN/A
OCF growth 5YN/A